We are live on
!
Find out more
SP
SWS Partners Portfolio holdings
AUM
$463M
1-Year Est. Return
41.78%
This Fund
S&P 500
This Quarter
Est. Return
-18.19%
1 Year Est. Return
+41.78%
3 Year Est. Return
+111.82%
5 Year Est. Return
+105.26%
10 Year Est. Return
–
AUM
$119M
AUM Growth
-$34.1M
(-22%)
Cap. Flow
-$2.38M
Cap. Flow
% of AUM
-2.01%
Top 10 Holdings %
Top 10 Hldgs %
24.6%
Holding
111
New
1
Increased
47
Reduced
20
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Cognizant
CTSH
|
+$785K |
| 2 |
NEWR
New Relic, Inc.
NEWR
|
+$664K |
| 3 |
MP Materials
MP
|
+$588K |
| 4 |
Snowflake
SNOW
|
+$575K |
| 5 |
LyondellBasell Industries
LYB
|
+$569K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$1.04M |
| 2 |
SFIX
Stitch Fix
SFIX
|
+$1.02M |
| 3 |
Merck
MRK
|
+$670K |
| 4 |
Bristol-Myers Squibb
BMY
|
+$611K |
| 5 |
Meta Platforms (Facebook)
META
|
+$592K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.86% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 11.88% |
| 4 | Consumer Discretionary | 11.55% |
| 5 | Communication Services | 10.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
McDonald's
MCD
$195B
| – | – |
-55
| Closed | -$14K |
|
102
Northrop Grumman
NOC
$79.2B
| – | – |
-27
| Closed | -$12K |
|
|
NVO
103
Novo Nordisk
NVO
$197B
| – | – |
-1,138
| Closed | -$63K |
|
104
Oracle
ORCL
$416B
| – | – |
-285
| Closed | -$24K |
|
105
Paychex
PAYX
$42.1B
| – | – |
-123
| Closed | -$17K |
|
106
PepsiCo
PEP
$189B
| – | – |
-354
| Closed | -$59K |
|
107
Pfizer
PFE
$147B
| – | – |
-1,000
| Closed | -$52K |
|
108
Philip Morris
PM
$294B
| – | – |
-422
| Closed | -$40K |
|
|
SFIX
109
Stitch Fix
SFIX
$550M
| – | – |
-101,330
| Closed | -$1.02M |
|
110
AT&T
T
$158B
| – | – |
-1,417
| Closed | -$25K |
|
111
Tesla
TSLA
$1.27T
| – | – |
-729
| Closed | -$262K |
|
Similar funds
CWWM
CPIM
FNBTCON
NG
PC
AC
PRCP
GLAM
SWS Partners's Q2 2022 Portfolio in Review
As of Q2 2022, SWS Partners held 111 positions worth $119M, down 22% from $153M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
SWS Partners's Q2 2022 filing shows 1 new, 47 increased, 20 reduced and 42 closed positions. Its largest new stake was MP Materials: 14,572 shares worth $467K. The largest sale was Edwards Lifesciences, an estimated $1.04M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 30% a quarter earlier, followed by Healthcare and Financials.
- SWS Partners's largest Q2 2022 buy was MP Materials: 14,572 shares worth $467K.
- SWS Partners added most to Cognizant in Q2 2022, an estimated $785K increase.
- SWS Partners's biggest Q2 2022 reduction was Merck, cutting an estimated $670K.
- SWS Partners fully exited Edwards Lifesciences in Q2 2022, selling an estimated $1.04M.
- SWS Partners's ten largest holdings make up 25% of its $119M portfolio in Q2 2022.
- SWS Partners opened 1 new position and closed 42 in Q2 2022.
- SWS Partners's portfolio value fell 22% quarter-over-quarter to $119M.
Based on SWS Partners's 13F filing for Q2 2022, filed 28 Jul 2022.